← All trials
NCT03697239
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2019
- Primary completion
- Dec 31, 2021
- Completion date
- Dec 31, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- —
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of California, San DiegoLead sponsor
- University of California, San DiegoOverall official - principal investigator
- University of California, San DiegoSponsor investigator
- Cancer Research UKCollaborator
- Stand Up To CancerCollaborator
- TGen Drug DevelopmentCollaborator
- Lustgarten FoundationCollaborator
- HonorHealth Research InstituteCollaborator
- Destroy Pancreatic CancerCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.